Bisimidazolium Salt Glycosyltransferase Inhibitors Suppress Hepatocellular Carcinoma Progression In Vitro and In Vivo
Hepatocellular carcinoma is a leading cause of cancer death, and the disease progression has been related to glycophenotype modifications. Previously synthesized bisimidazolium salts (C20 and C22) have been shown to selectively inhibit the activity of glycosyltransferases in cultured cancer cell hom...
Main Authors: | Xue Luan, Ming Sun, Xue Zhao, Jingyi Wang, Ye Han, Yin Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/6/716 |
Similar Items
-
Synthesis and Preliminary Biological Evaluations of 5′-Substituted Derivatives of Uridine as Glycosyltransferase Inhibitors
by: Ilona Wandzik, et al.
Published: (2013-07-01) -
Inhibition of Streptococcus mutans polysaccharide synthesis by molecules targeting glycosyltransferase activity
by: Zhi Ren, et al.
Published: (2016-04-01) -
Production of cyclodextrins using immobilized cyclodextrin glycosyltransferase /
by: 274380 Rutchtorn, U., et al. -
Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents
by: Yingqian Zhang, et al.
Published: (2023-08-01) -
Production and Characterisation of Cyclodextrin Glycosyltransferase from a Locally Isolated Bacillus Sp
by: Ai Noi, Sauvaphap
Published: (2006)